YY, S., Q, Z., QB, D., YJ, G., YX, B., & MF, L. The Prognostic Value of Systemic Immune-Inflammation Index Supporting Age-Adjusted Charlson Comorbidity Index in Non-Small Cell Lung Cancer Patients with First-Line Platinum-Based Chemotherapy. Dove Medical Press.
Chicago Style (17th ed.) CitationYY, Sheng, Zhu Q, Dai QB, Gao YJ, Bai YX, and Liu MF. The Prognostic Value of Systemic Immune-Inflammation Index Supporting Age-Adjusted Charlson Comorbidity Index in Non-Small Cell Lung Cancer Patients with First-Line Platinum-Based Chemotherapy. Dove Medical Press.
MLA (9th ed.) CitationYY, Sheng, et al. The Prognostic Value of Systemic Immune-Inflammation Index Supporting Age-Adjusted Charlson Comorbidity Index in Non-Small Cell Lung Cancer Patients with First-Line Platinum-Based Chemotherapy. Dove Medical Press.